Regencell Bioscience Holdings Ltd

RGC

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
RGC
CIK0001829667
SIC2833
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupMedicinal Chemicals

Contact

Address11/F FIRST COMMERCIAL BUILDING, 33-35 LEIGHTON ROAD, CAUSEWAY BAY, HONG KONG, K3, 999077
Website regencellbioscience.com
Phone852 2155 0823
CEOYat-Gai Au
Employees10

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$0.00
Pre-Tax Income$-4.36 million
Net Income$-8.67 million
Net Income to Common$-4.30 million
EPS$-0.33
View All
Balance Sheet
Cash$2.96 million
Assets$8.44 million
Liabilities$219,512.00
Common Equity$8.22 million
Liabilities & Equity$8.44 million
View All
Cash Flow Statement
Calculations
NOPAT$-3.32 million
EBITDA$-3.62 million
Price to EarningsN/A
Price to Book$1,047.50
ROE-85.76%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Regencell Bioscience Holdings Limited (RGC) Added to S&P Global BMI Index Amid Positive ADHD/ASD Trial Results

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Regencell Bioscience Holdings Limited is one of them. Regencell Bioscience Holdings Limited (NASDAQ:RGC) tops our list for being one of the stocks with insider buying. It is a Hong Kong-based biopharmaceutical company developing Traditional Chinese Medicine (TCM) treatments for neurocognitive disorders […]

Article Link

Regencell Bioscience Holdings (RGC) Climbs 11% Over Last Week

Regencell Bioscience Holdings (RGC) experienced a 10.9% price increase over the past week despite no specific company-related events attracting attention. This movement aligns with broader market trends, as the Nasdaq Composite reached a record high and major indices posted weekly gains, likely supporting RGC's positive performance. While the company's specific activities last week did not significantly impact the market directly, they coincided with a positive investor sentiment driven by...

Article Link

Sarah Weber Named Board Chair of Relevant Gold

VANCOUVER, BC / ACCESS Newswire / September 9, 2025 /Relevant Gold Corp. (TSXV:RGC)(OTCQB:RGCCF) (the "Company" or "Relevant Gold") is pleased to announce that Sarah Weber, P.Geo., has been appointed Independent Chair of the Board, effective immediately. ...

Article Link

Nasdaq Revamps Listing Rules for Small IPOs, Chinese Firms

The exchange operator proposed a set of new standards that small companies listing on Nasdaq must abide by, according to a statement Wednesday. For example, shares of Regencell Bioscience Holdings Ltd., a Hong Kong-based traditional Chinese medicine company with no sales, exploded 82,000% higher this year before retreating.

Article Link

Regencell Bioscience (RGC) Nosedives 19.8% on Profit-Taking

Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) is one of the 10 Stocks Crash Hard Alongside Wall Street. Regencell Bioscience fell by 19.83 percent on Monday to close at $18.43 apiece as investors appeared to have taken profits following Friday’s 122-percent surge. Monday’s drop, however, was primarily due to the lack of catalysts to support investing appetite, with […]

Article Link